Algene Holding SE, a subsidiary of DN Group AG (ISIN: DE000A3DW408), has announced the first harvest of high-purity microalgae, achieving a total yield of 4,500 liters. This milestone marks the start of series production after successful up-scaling, positioning Algene to supply quality-critical products in the cosmetics, food, and pharmaceutical industries.
The Algene platform, developed in cooperation with the Technical University of Munich, will now commence series production. Algene has entered extensive talks with well-known cosmetics companies and plans its initial delivery to a leading German cosmetics manufacturer in the coming days. The biomass from this first delivery will be used primarily for laboratory tests and validation of active ingredients.
The microalgae market is growing dynamically. According to the EU Commission, the European market alone is projected to reach approximately 9 billion euros by 2030. Algae are considered a key building block of the bioeconomy, and Algene is positioning itself as an industrial platform for controlled microalgae production, addressing markets such as nutrition & food, cosmetics, life sciences, and aquaculture.
Ole Nixdorff, CEO of DN Group, stated: "For Algene, the start of series production is an important milestone. The market for microalgae is growing rapidly and offers enormous potential. The high level of interest underlines the high quality of the Algene material and the good market acceptance. As a shareholder in Algene, DN Group participates in this future market."
DN Group AG invests in impact companies with high growth opportunities in future industries such as AI, mobility, circular economy, food, health, and energy, and supports them in successful IPOs. The company provides IPO and capital market transaction advice and connects fast-growing ESG companies with international institutional investors. More information can be found at https://www.dn-ag.com.
View the original release on https://www.newmediawire.com.
